%0 Journal Article
%T Genetics and biomarker in bladder cancer for optimized clinical decision-making and improved outcomes
%A Rink, Michael
%J Translational Andrology and Urology
%D 2017
%B 2017
%9 
%! Genetics and biomarker in bladder cancer for optimized clinical decision-making and improved outcomes
%K 
%X Urothelial carcinoma is the second most common urological malignancy after prostate cancer and with approximately estimated 79,000 newly diagnosed cases and 16,800 deaths in the United states in 2017 a significant burden of morbidity and mortality (1).
%U https://tau.amegroups.org/article/view/17656
%V 6
%N 6
%P 1014-1017
%@ 2223-4691